BioMarin Pharmaceutical | Försäljning



Sales Ändra Datum
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amgen USD 9.09B 583M 2024-12
Bayer EUR 11.73B 1.76B 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Gilead Sciences USD 6.67B 899M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



BioMarin Pharmaceutical Försäljning - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.